Taken together, 22E6 may have a growth delaying effect on CD73 positive ALL cells in vivo, but the leukemia cells quickly became resistant to the treatment by downregulating CD73 or by selection for a CD73dim/neg subpopulation. This evidence concerns the gene NT5E and acute lymphoblastic leukemia.